MFN Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.6M Hold
6,000,000
0.61% 6
2026
Q1
$32.4M Hold
6,000,000
0.68% 7
2025
Q4
$41.7M Hold
6,000,000
0.88% 8
2025
Q3
$38.7M Hold
6,000,000
0.78% 8
2025
Q2
$40M Hold
6,000,000
0.86% 8
2025
Q1
$38.8M Hold
6,000,000
0.91% 9
2024
Q4
$48.4M Hold
6,000,000
0.95% 9
2024
Q3
$49M Hold
6,000,000
0.97% 9
2024
Q2
$41.8M Hold
6,000,000
1.42% 7
2024
Q1
$63.7M Hold
6,000,000
1.81% 8
2023
Q4
$48.1M Hold
6,000,000
1.55% 9
2023
Q3
$49.3M Hold
6,000,000
1.66% 10
2023
Q2
$48M Hold
6,000,000
1.56% 11
2023
Q1
$48.6M Hold
6,000,000
2.2% 9
2022
Q4
$37.7M Hold
6,000,000
1.66% 10
2022
Q3
$41.3M Buy
+6,000,000
New +$41.7M 1.87% 11

Other funds holding BHC

MFN Partners's BHC Position: Q2 2026 in Review

MFN Partners held its Bausch Health (BHC) position steady in Q2 2026 at 6,000,000 shares worth $29.6M. The position accounts for 0.61% of the portfolio, ranked #6.

MFN Partners first reported a position in BHC in Q3 2022 and has held it in 16 quarters since. The position peaked at $63.7M in Q1 2024. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • MFN Partners held 6,000,000 shares of Bausch Health worth $29.6M as of Q2 2026.
  • MFN Partners left its Bausch Health share count unchanged in Q2 2026.
  • Bausch Health made up 0.61% of MFN Partners's portfolio in Q2 2026, its #6 holding.
  • MFN Partners first reported a position in Bausch Health in Q3 2022 and has held it in 16 quarters since.
  • MFN Partners's Bausch Health position peaked at $63.7M in Q1 2024.
  • 222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on MFN Partners's 13F filing for Q2 2026, filed 12 Aug 2026.